Bob Hoban — Cannabis Law Sources

“Moving cannabis to Schedule III is the most consequential federal action since the Controlled Substances Act. It does not legalize cannabis, but it obliterates the 280E tax wall that has starved the industry of capital for a decade.”

“Section 280E is the most punishing provision in the tax code for a legal American industry. Cannabis businesses pay effective federal rates of 70 percent or more because ordinary business deductions are stripped away. Structuring around it is not tax evasion — it is essential business architecture.”

“The FDA's failure to establish a regulatory pathway for CBD as a dietary supplement after five years of deliberation is not bureaucratic inertia — it is a policy choice with winners and losers. The losers are small hemp companies and consumers who deserve clarity. The winners are pharmaceutical interests and incumbent food companies.”

“Cannabis M&A is entering a consolidation cycle driven by distressed multiples, operator fatigue, and institutional capital that has been waiting for rescheduling clarity. The buyers in this market are sophisticated and patient. Sellers who have not cleaned up their cap tables and compliance records will be picked apart in diligence.”

“States banning delta-8 without corresponding hemp program reform are creating regulatory arbitrage that will collapse the moment federal hemp rules tighten. The litigation posture for banned delta-8 operators is defensible in some jurisdictions, but operators should be building exits — not digging in.”

“The global cannabis market is fragmenting into regulatory regimes that are moving faster than most American operators realize. Germany, the UK, and Thailand have taken divergent approaches to adult use and medical access. Operators building international strategies without country-specific legal counsel are building on sand.”

“The 2018 Farm Bill created a regulatory gap that the FDA was never resourced to close. Intoxicating hemp derivatives now occupy a legal gray zone that will not survive the next farm bill reauthorization — operators who have built businesses on that gray zone need contingency plans now.”

“The psychedelic regulatory arc is following the cannabis playbook about a decade behind — ballot initiatives, medical carve-outs, and regulatory frameworks that are more restrictive than the science requires. Operators entering this space should expect a long regulatory runway and plan accordingly.”

“The SAFER Banking Act's failure is not a legislative fluke — it reflects the structural tension between federal scheduling and state-legal commerce. Until that tension resolves, cannabis will remain a cash-heavy, bank-excluded industry that is disproportionately vulnerable to crime and regulatory overreach.”

“Every state licensing window is a short-duration high-stakes event. The operators who perform well are the ones who treat the application as a product launch — months of preparation, assembled teams, and documented compliance infrastructure — not a form-filling exercise.”

“IRC 471(c) is one of the most underutilized tools available to cannabis operators. It allows simplified cost accounting that can expand COGS deductions under 280E — but only if the operator implements it correctly and can survive IRS scrutiny. This is not a DIY tax strategy.”

“Cannabis litigation is reaching maturity — we are seeing the same contract disputes, employment claims, real estate battles, and investor fraud cases that characterize any established industry. The difference is that cannabis defendants face a federal illegality defense that courts have treated inconsistently.”

“Cannabis company failures are uniquely complicated because the assets — licenses, inventory, real estate — are encumbered by state regulatory requirements that bankruptcy courts were not designed to navigate. Receivership is often the only viable path, but it requires cannabis-specific expertise that most restructuring attorneys do not have.”

“The USPTO's refusal to register cannabis trademarks on federal lawfulness grounds leaves operators exposed in ways that most do not appreciate until a competitor infringes. State-level trademark registration and common-law use rights are the available tools — but they require a deliberate strategy, not an afterthought.”

“Tribal cannabis operates in a genuinely distinct legal space — tribal sovereignty can preempt state licensing requirements on tribal land, but federal law still applies and tribal-state compacts determine practical market access. The legal architecture is complex and the due diligence required before entering a tribal cannabis deal is substantial.”

“The Cole Memo's rescission in 2018 produced far less federal enforcement disruption than many predicted — because federal prosecutors had already de-prioritized compliant state-licensed cannabis under resource constraints. What the rescission did do is remove the safe-harbor inference and put operators back in the position of relying on prosecutorial discretion rather than written policy.”

“Multi-state operators face a structural legal challenge that single-state operators do not: every state you enter adds a new regulatory relationship, a new compliance calendar, and a new political risk surface. The MSOs that have survived downturns are the ones that treated regulatory infrastructure as a core competency, not a cost center.”

“Social equity programs were designed to repair the disproportionate harm of the war on drugs. In practice, many of them have become a vehicle for delay, extractive fee structures, and capital traps that leave equity applicants worse off than they started. The programs that work share one feature: they pair license access with patient, low-cost technical assistance.”

“The USDA hemp program established compliance infrastructure — testing protocols, sampling requirements, disposal rules — that the industry underestimated at launch. Four years in, the operators who treated the USDA requirements as a floor rather than a ceiling have built defensible businesses. The ones who treated them as a compliance checkbox have accumulated liability.”

“The vertically integrated cannabis operator has a regulatory advantage in control and a capital disadvantage in execution. The licensing-only operator has the inverse. The right structure depends on the state, the capital stack, and the operator's core competency — and I have seen both models succeed and fail at scale.”